![]() |
|
![]() |
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Alcon Research |
Information provided by: | Alcon Research |
ClinicalTrials.gov Identifier: | NCT00578474 |
The purpose of this study is to determine if AL-15469A / AL-38905 is safe and effective in treating middle ear infections in patients with ear tubes.
Condition | Intervention | Phase |
Acute Otitis Media With Tympanostomy Tubes |
Drug: AL-15469A / AL-38905 |
Phase III |
MedlinePlus related topics: | Ear Infections |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment |
Official Title: | Safety and Efficacy of a Topical Otic Formulation in the Treatment of Acute Otitis Media With Otorrhea Through Tympanostomy Tubes (AOMT) |
Estimated Enrollment: | 800 |
Study Start Date: | December 2005 |
Primary Completion Date: | August 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
2: Active Comparator
ofloxacin 0.3%
|
Drug: AL-15469A / AL-38905
Ear drops
|
1: Active Comparator
AL-15469A/AL-38905
|
Drug: AL-15469A / AL-38905
Ear drops
|
Ages Eligible for Study: | 6 Months to 12 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | Alcon ( Sheryl Dupree ) |
Study ID Numbers: | C-05-35 |
First Received: | December 19, 2007 |
Last Updated: | September 18, 2008 |
ClinicalTrials.gov Identifier: | NCT00578474 |
Health Authority: | United States: Food and Drug Administration |
|
![]() |